Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation "MISTIE"


Phase 2 Results

Summary of Purpose

The purpose of this trial is to determine the safety of using a combination of minimally invasive surgery and clot lysis with rt-PA to remove intracerebral hemorrhage (ICH). The ICES arm of the trial will determine the safety of endoscopic surgery to remove ICH. All MISTIE intention to treat subjects represent the hypothesized test group. The ICES cohort is to be analyzed separately.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 June 2015.

1 Aug 2005 21 Sep 2005 1 Aug 2012 1 Apr 2013 1 Jun 2015 21 Sep 2014
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment